secwatch / observer
8-K filed November 22, 2022, 6:59 PM ET ticker HUM CIK 0000049071
debt confidence high sentiment neutral materiality 0.50

HUMANA INC (HUM): debt financing — Humana closes $1.25B senior notes offering to refinance maturing 2022 debt

HUMANA INC

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

HUMANA INC incurred senior notes of $750 million with The Bank of New York Mellon Trust Company, N.A. at 5.875% maturing March 1, 2033.

Instrument
senior notes
Principal
$750 million
Counterparty
The Bank of New York Mellon Trust Company, N.A.
Rate
5.875%
Maturity
March 1, 2033
Event
incurrence
Exact text from the filing
The Senior Notes were issued under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”) (the “Original Indenture”), as supplemented by a twenty-second supplemental indenture, dated as of November 22, 2022, by and between the Company and the Trustee relating to the 2028 Senior Notes (the “Twenty-Second Supplemental Indenture” and, together with the Original Indenture, the “Twenty-Second Indenture”) and a twenty-third supplemental indenture, dated as of November 22, 2022, by and between the Company and the Trustee relating to the 2033 Senior Notes (the “Twenty-Third Supplemental Indenture” and, together with the Original Indenture, the “Twenty-Third Indenture,” and the Twenty-Second Indenture and T
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

HUMANA INC incurred senior notes of $500 million with The Bank of New York Mellon Trust Company, N.A. at 5.750% maturing March 1, 2028.

Instrument
senior notes
Principal
$500 million
Counterparty
The Bank of New York Mellon Trust Company, N.A.
Rate
5.750%
Maturity
March 1, 2028
Event
incurrence
Exact text from the filing
completed a public offering of $500 million aggregate principal amount of its 5.750% Senior Notes due 2028
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HUMANA INC entered into Twenty-Second Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee valued at $500 million aggregate principal amount (effective 2022-11-22).

Action
entry
Agreement
notes offering
Counterparty
The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee
Value
$500 million aggregate principal amount
Effective
2022-11-22
Exact text from the filing
a twenty-second supplemental indenture, dated as of November 22, 2022, by and between the Company and the Trustee relating to the 2028 Senior Notes
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HUMANA INC entered into Twenty-Third Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee valued at $750 million aggregate principal amount (effective 2022-11-22).

Action
entry
Agreement
notes offering
Counterparty
The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee
Value
$750 million aggregate principal amount
Effective
2022-11-22
Exact text from the filing
a twenty-third supplemental indenture, dated as of November 22, 2022, by and between the Company and the Trustee relating to the 2033 Senior Notes
View on SEC.gov

Browse all debt financings →

HUMANA INC filing history →

Source: SEC EDGAR
accession 0001193125-22-291138
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.